Canada Pension Plan Investment Board’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
NAMA
Canada Pension Plan Investment Board's PACB Position: Q2 2026 in Review
Canada Pension Plan Investment Board reduced its Pacific Biosciences (PACB) stake by 69% in Q2 2026, selling an estimated $108K and leaving 33,400 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.
Canada Pension Plan Investment Board first reported a position in PACB in Q4 2018 and has held it in 14 quarters since. The position peaked at $10M in Q4 2018. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Canada Pension Plan Investment Board held 33,400 shares of Pacific Biosciences worth $56.1K as of Q2 2026.
- Canada Pension Plan Investment Board sold 74,400 Pacific Biosciences shares in Q2 2026, an estimated $108K.
- Pacific Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1688 holding.
- Canada Pension Plan Investment Board first reported a position in Pacific Biosciences in Q4 2018 and has held it in 14 quarters since.
- Canada Pension Plan Investment Board's Pacific Biosciences position peaked at $10M in Q4 2018.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.